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To the Editor: Lehman and Guercio conclude that the U.S. Medical Licensing Examination (USMLE) Step 2 Clinical Skills (CS) exam produces a poor return on investment. Their computation is based on the explicit costs of the exam to students. They evaluate the benefits only in terms of screening out unqualified applicants. Lehman and Guercio do not consider that requiring passage of Step 2 CS has also compelled medical schools to bolster clinical-skills education in their curricula.
Every exam should correspond to educational activities in which students learn the knowledge and skills needed to pass that exam. 1 Delivering a preparatory curriculum for licensure exams is an ethical obligation for medical schools. A substantial benefit of Step 2 CS stems from curricular innovations that medical schools have made to prepare students for the exam. Contemporary curricula include instruction in fundamental clinical skills and inculcation of the importance of those skills.
An investment cannot be measured exclusively by its cost, but rather, the cost must be balanced against the benefit realized from the expenditure. In this case, Lehman and Guercio discounted the value of the curriculum innovations that occurred in response to the imposition of Step 2 CS. Hugh A. Stoddard, Ph.D.
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The Authors Reply: Huwendiek et al. argue that the USMLE Step 2 CS exam "filter[s] out candidates in need of remediation." As shown, because of the high pass rates, the exam annually filters out only 32 candidates who fail the exam twice. Since candidates may take the exam six times, 1 Step 2 CS only delays -but does not filter out -the practice of medicine by any future physician. Furthermore, we question the notion that "without a mandatory high-stakes clinical skills exam, too many new graduates may lack the clinical skills deemed critical to effective health care." This statement incorrectly implies that passing a high-stakes clinical exam ensures a sufficient level of clinical skills. This belief is as erroneous as the contrapositive of the argument, that physicians who have not passed a clinical skills exam lack a sufficient clinical skill set. The test was instituted in 2004, so this logic raises the question of whether hundreds of thousands of otherwise-licensed physicians are truly clinically competent, given that they graduated without taking Step 2 CS. We agree with Stoddard that there may be benefits stemming from curriculum innovations designed "in response to the imposition of Step 2 CS." But this statement is telling: medical schools are teaching (and thus students are learning) for a test. The argument prompts the question of whether a costly, daylong exam -as opposed to Liaison Committee on Medical Education guidelines or regulations -is truly the best mechanism for ensuring the clinical skills that all physicians must have on graduating from medical school.
Our Perspective article did not claim to be an exhaustive cost-benefit analysis. It did, however, highlight a major cost borne directly by physicians and question a nebulous benefit that neither the National Board of Medical Examiners nor the Federation of State Medical Boards has definitively quantified.
Step 2 CS serves as little more than an expensive rubber stamp on top of a student's medical education. We believe it should be eliminated, unless its benefits -like those of any other medical intervention -are conclusively shown. Elmer Philip Lehman IV, M.D., M.P.P. Jason Ross Guercio, M.D., M.B.A.
